<DOC>
	<DOCNO>NCT01339988</DOCNO>
	<brief_summary>Long-term follow-up study demonstrate significant late toxicity total body irradiation ( TBI ) , mark child radiate young age . Growth failure , decline cognitive function , endocrine abnormality describe . Good outcome achieve alkylating agent preparative regimen . This plan use combination busulfan cyclophosphamide ( Bu/Cy ) without antithymocyte globulin ( ATG ) reduce late toxicity therapy include TBI .</brief_summary>
	<brief_title>Busulfan Cyclophosphamide Instead Total Boby Irradiation ( TBI ) Cyclophosphamide Hematological Malignancies Hematocrit ( HCT )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Juvenile</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Suitable cord blood match unrelated related donor . Cardiac ( Echo/EKG ) : shorten fraction ≥ 27 % Electrolytes within normal CCHMC limit . Pulmonary function test : DLCO ≥ 50 % Renal : creatinine clearance/GFR ≥ 60 ml/minute/1.73m2 Lumbar puncture : leukemic infiltrate . CBC : ANC ≥ 1000ml unsupported platelet count ≥ 50,000/ml Documented HSV CMV titer , Hepatitis B surface antigen , Hepatitis C serology , HIV serology : negative . Hepatic transaminase &lt; 2.5x normal ; Total bilirubin &lt; 2 mg/dl Patients meet organ function criterion ( liver , cardiac , renal ) , due presence tumor compromise organ , may exception make criterion remain eligible treatment plan consultation Program Director Blood Marrow Transplant Patients neoplastic nonneoplastic disease major organ system would compromise ability withstand pretransplant condition regimen . Patients uncontrolled ( culture biopsy positive ) infection require intravenous antiviral , antibiotic , antifungal . Patients prolonged antifungal therapy history fungal infection consider nonmyeloablative protocol . Patients pregnant lactate . Patients childbearing potential must practice effective method birth control participate treatment plan . HIV seropositive patient</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Stem-cells</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Busulfex</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Total-Body-Ittadiation</keyword>
</DOC>